(Q37277211)

English

PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

scientific article published on 16 June 2016

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit